Phase III Trial of Stage I Ovarian Cancer After Surgery

To compare the Overall survival of adjuvant chemotherapy versus observation in stage I epithelial ovarian cancer after comprehensive staging surgery

Trial Details

NCT ID
NCT04063527
Phase
PHASE3
Sponsor
Japanese Gynecologic Oncology Group
Status
RECRUITING
Cancer Type
Ovarian Cancer
Interventions
  • adjuvant chemotherapy
Locations (sample)
  • Nagakute-shi, Aichi-ken, Japan
  • Hirosaki-shi, Aomori, Japan
  • Kashiwa-shi, Chiba, Japan
  • Onsen-gun, Ehime, Japan
  • Fukuoka, Fukuoka, Japan|33.6,130.41667

Key Eligibility Criteria

  • Patients with a diagnosis of histopathologically epithelial ovarian cancer
  • FIGO Stages Ia(Grade2/3, clear cell carcinoma), Ib(Grade2/3, clear cell carcinoma) and Ic(b)(all degree of differentiation and all histologic type)
  • Patients with a diagnosis of advanced stage by comprehensive staging or restaging laparotomy.
  • Patients who received comprehensive staging surgery (basic surgical techniques (total hysterectomy, bilateral salpingo-oophorectomy, and omentectom…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Ovarian Cancer Trials on Trialify →